Literature DB >> 15300628

[Association of APOA5 gene single nucleotide polymorphism with levels of lipids and coronary heart disease in Chinese].

He-kun Liu1, Chun-ting Wang, Si-zhong Zhang, Cui-ying Xiao, Xue-fei Li, Ke-lan Zhang, Li Zhang, Zhi-guang Su, Yong-xin Ma, Bin Zhou, Ke-qin Zheng, Gui-xing Li.   

Abstract

OBJECTIVE: To investigate the single nucleotide polymorphism 4 (SNP4) of the apolipoprotein A5 (APOA5) gene possible association with coronary heart disease(CHD) and its distribution of in Chinese Han population.
METHODS: APOA5 SNP4 genotyping was performed using polymerase chain reaction and Hae III restriction fragment length polymorphism analysis.
RESULTS: APOA5 allelic frequencies of T, C were 0.435, 0.565 and 0.374, 0.626 in CHD group and control group, respectively. There is significant difference in allele and genotype frequencies between CHD group and control group (P<0.05). The levels of plasma high density lipoprotein in CHD patients with CC genotype were higher than those in CHD patients with other genotypes (P<0.01). The frequencies of T allele and C allele in Chinese was significantly different from those in Caucasians (0.374 vs 0.663, 0.626 vs 0.337, P<0.01). The C allele was much more common in Chinese population.
CONCLUSION: The association is found between the Hae III polymorphism and CHD, There is a significant correlation between the CC genotype of the APOA5 and the levels of plasma high density lipoprotein-cholosteal in the CHD group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300628

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  6 in total

1.  APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.

Authors:  Elizabeth Suchi Chen; Tatiane Katsue Furuya; Diego Robles Mazzotti; Vanessa Kiyomi Ota; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Lipids       Date:  2010-05-18       Impact factor: 1.880

2.  Association of APOA5 T1131C polymorphism and risk of coronary artery disease.

Authors:  Jing Xia; Weiping Cai; Caosheng Peng
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene.

Authors:  Kirsten J Ward; Sian Ellard; Chittaranjan S Yajnik; Timothy M Frayling; Andrew T Hattersley; Prathyusha N S Venigalla; Giriraj R Chandak
Journal:  Lipids Health Dis       Date:  2006-05-02       Impact factor: 3.876

4.  Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS).

Authors:  Uppala Radhakrishna; Samet Albayrak; Zeynep Alpay-Savasan; Amna Zeb; Onur Turkoglu; Paul Sobolewski; Ray O Bahado-Singh
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

Review 5.  The role of DNA methylation in syndromic and non-syndromic congenital heart disease.

Authors:  Jiali Cao; Qichang Wu; Yanru Huang; Lingye Wang; Zhiying Su; Huiming Ye
Journal:  Clin Epigenetics       Date:  2021-04-26       Impact factor: 6.551

6.  Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis.

Authors:  Jianqing Zhou; Limin Xu; Rong Stephanie Huang; Yi Huang; Yanping Le; Danjie Jiang; Xi Yang; Weifeng Xu; Xiaoyan Huang; Changzheng Dong; Meng Ye; Jiangfang Lian; Shiwei Duan
Journal:  Mol Med Rep       Date:  2013-08-16       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.